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Case Report
Colonic Migration of a Nephroureteral Stent
Through a Colovesical Fistula
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We describe a case of a patient with a two-year history of prostate cancer who underwent placement of nephroureteral stents. He subsequently presented to the hospital with
complications from prolonged retention of the stents, which ultimately lead to a secondary
diagnosis of adenocarcinoma of the rectum. A colonoscopy performed approximately two
weeks after a bilateral nephroureteral tube exchange demonstrated what was believed to
be locoregional metastatic disease and a fistulous connection with the distal nephroureteral
stents. Radiographic features of this complication are discussed together with proper management and possible complications of distal nephroureteral stents. Both nephroureteral
stents were explanted, and nephrostomy catheters were sequentially replaced to allow for
healing of the fistula.
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Introduction

Nephroureteral stents were first developed in
the 1960s and play a fundamental role in urological focused medicine. They are one of the
most commonly used urological devices today
and allow for the creation of ureteral patency
and drainage of the urinary system.1 Although
beneficial to patient care, stents are not without their risks or adverse reactions. These
complications include urinary tract infections,
malposition, migration, inadequate relief of obstruction, encrustation, stent fracture, urethral
erosion or fistulization, prolonged retention of
stents due to neglect or oversight, hematuria and pain.2 Risk factors are associated with
symptoms of bladder irritation and inflammation and occur in up to 80% of patients.2 The
complication risk increases with prolonged
stenting.3 Rare cases of ureterocolic fistulae
have occurred in the older polyethylene4 and
self-expandable ureteral stents.5 We present
a case of an older male with chronic ureteral
obstruction requiring long-term diversion with
bilateral nephroureteral stents who developed
a colovesical fistula.

Case Presentation

The patient is a 77-year-old Hispanic male
with a history of prostate cancer status post
prostatectomy, which was followed by cycles
of chemoradiotherapy and adjuvant bilateral
nephroureteral stent and nephrostomy placement for obstructive uropathy. He presented
approximately two years after multimodal
therapy with hematochezia, foul-smelling,
brown-colored urine and pneumaturia. Laboratory and physical work revealed the patient had
an elevated white count and met sepsis criteria. Blood cultures were obtained revealing bacteremia for which the patient was treated with
empiric antibiotic therapy. An imaging workup,
including a non-contrasted CT of the abdomen
and pelvis, demonstrated a large pelvic mass
involving the urinary bladder closely associated
with the distal nephroureteral stents. (Figure 1)
An immediate colonoscopy was delayed, and,
in the interim, the patient received an uncomplicated scheduled nephroureteral stent replacement under direct fluoroscopy with two 8
French 24 cm catheters. A subsequent colonoscopy performed approximately two weeks after
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Figure 1. CT demonstrated a large pelvis mass involving the rectum and urinary bladder that enveloped the distal nephroureteral stents.
the bilateral nephroureteral tube exchange
demonstrated what was believed to be locoregional metastatic disease and a fistulous connection with the distal nephroureteral stent.
(Figure 2) The fistulous connection posed a
clear risk for urosepsis and the interventional
radiology service was consulted for the replacement of the nephroureteral stents. Histologic
evaluation of the pelvis mass confirmed rectal
adenocarcinoma with aggressive local spread.
A subsequent nephrostogram was concerning
for enteral contrast, and both nephroureteral stents were explanted. The nephrostomy
catheters were sequentially replaced, which
allowed the collecting system to be drained
and for the fistula to remain relatively dry as
well as to heal. Due to advanced locoregional
disease involving the rectum and distal ureters,

no further palliative care was considered, and
the patient entered hospice care.

Discussion

We describe a case of a patient who required
adjuvant stent placement after multimodal
therapy for prostate cancer who subsequently
presented with locally invasive adenocarcinoma
of the rectum. The underlying pathophysiology of the migration can be debated. However,
it is likely that enteral and subsequent ureteral wall compromise by local carcinomatous
invasion was the precipitating factor for stent
migration. It is unlikely that this migration was
an immediate iatrogenic complication as the
patient’s symptoms of hematochezia predated the most recent stent placement by three
months.
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Figure 2. A fungating, infiltrative and ulcerated non-obstructing large mass was found in the
rectum that proved on pathology to be a rectal adenocarcinoma. A large fistula, from the bladder
with nephroureteral stents protruding through, was found in the rectum.
192

Pigg et al. (2021) 2:3. https://doi.org/10.36518/2689-0216.1073

Nephroureteral stents are widely used within
interventional radiology and urological medicine to treat urinary system obstructions,
whether from obstructive urolithiasis, anatomical variants, inflammation, infection or malignancy.6 They are often placed as a first-line
treatment in patients with such obstructions
and when presenting with hydronephrosis,
pyelonephritis or renal injury.6 The procedures
are often quick and have been shown to be
effective in relieving symptoms but also in
preventing further renal damage.7 These stents
have also been utilized in patients with chronic
renal conditions that need long-term drainage.
Within this particular group of patients complications increase in magnitude and frequency.7
Most complications of nephroureteral stents
are benign and range from mild hematuria to
urinary tract infection to bladder irritation.2
However, in select patient groups, the complications can become far more serious. These
groups most often consist of patients with the
long-term need for stent drainage or where
stents were forgotten. Studies have shown
that nearly 50% of these stents are left in
place for over three months with some being
forgotten for years or lost to follow-up.8 These
patients also tend to have many comorbidities
that make them even more susceptible to complications such as in the case of our patient.
One of the most dangerous complications
found with nephroureteral stents is fistula
formation. These fistulas can form almost anywhere and are a direct result of inflammation
caused by long-term stent placement and/or
other comorbidities increasing the rate of fistula formation.9 Fistulas have been reported to
form between the ureters and bladder as well
as the iliac arteries, uterus, vagina and even
subcutaneously.10 These fistulas often result in
many complications, can cause harm and even
prove fatal in certain patients.10 No reported
enterovesical fistulas have been reported to
date. In our patient, a fistula formed between
the colon and bladder, resulting in pyelonephritis, sepsis and serious, near-fatal illness.
It has been shown that there is no significant
negative effect in removing nephroureteral
stents as early as possible in patients with resolving clinical symptoms.11 However, prolonged
stenting results in an increase in complica-

tions.8 Therefore, it is important we monitor
our patients with nephroureteral stents and
ensure proper follow-up, early detection of
complications and timely stent removal to
avoid significant morbidity or complications
within this patient population.

Conclusion

While nephroureteral stents are an invaluable
resource for the treatment of genitourinary
disease, complications related to their placement and management can adversely affect
patient morbidity and mortality. Understanding these inherent potential complications
improves the clinician’s ability to manage and
educate these patients.
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